NECTAR

 

Novel experimental COVID therapies affecting host response

​

Sponsor : NEAT ID Foundation & VUMC

​

Indication: COVID-19

​

Countries: Brazil, RSA, Germany, Spain, Italy & Argentina

​

 

Status: Early reporting and close down activities. The DSMB has stopped Fostamatinib for low conditional power of finding efficacy.

​

​